financetom
Business
financetom
/
Business
/
BRIEF-Gemini Raised $425 Million In An Initial Public Offering - Bloomberg News
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Gemini Raised $425 Million In An Initial Public Offering - Bloomberg News
Sep 11, 2025 4:16 PM

Sept 12 (Reuters) -

* GEMINI RAISED $425 MILLION IN AN INITIAL PUBLIC OFFERING,

PRICING ITS STOCK ABOVE A MARKETED RANGE AND SHRINKING THE

NUMBER OF SHARES- BLOOMBERG NEWS

* GEMINI SOLD ABOUT 15.2 MILLION SHARES THURSDAY FOR $28

EACH

AFTER MARKETING THEM FOR $24 TO $26 APIECE - BLOOMBERG NEWS

Source text: https://tinyurl.com/22cuussl

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
FTC Seeking Info From JPMorgan, Mastercard on 'Surveillance Pricing'
FTC Seeking Info From JPMorgan, Mastercard on 'Surveillance Pricing'
Jul 23, 2024
09:48 AM EDT, 07/23/2024 (MT Newswires) -- The US Federal Trade Commission said Tuesday it issued orders to JPMorgan Chase ( JPM ) , Mastercard ( MA ) , Accenture ( ACN ) and five other companies that offer surveillance pricing products and services that incorporate data about consumers' characteristics and behavior. The orders seek information about the potential impact...
US, Canadian pot firms eye Germany for growth as market stagnates at home
US, Canadian pot firms eye Germany for growth as market stagnates at home
Jul 23, 2024
By Sourasis Bose (Reuters) - North American cannabis firms, facing prohibitive laws, an overcrowded market and a deeply entrenched illicit sector at home are ramping up investments in Germany after the country partly legalized marijuana use. Germany, the largest medical cannabis market in Europe, decriminalized cannabis possession and small-scale home cultivation in April, making it easier for doctors to prescribe...
Enlivex Therapeutics Gets Regulatory Nod in Israel to Begin Phase I Trial for Potential Psoriatic Arthritis Treatment
Enlivex Therapeutics Gets Regulatory Nod in Israel to Begin Phase I Trial for Potential Psoriatic Arthritis Treatment
Jul 23, 2024
09:53 AM EDT, 07/23/2024 (MT Newswires) -- Enlivex Therapeutics ( ENLV ) said Tuesday it has received authorization from the Israeli Ministry of Health to start a phase I clinical trial to assess the safety and tolerability of Allocetra after injection into an affected joint in psoriatic arthritis patients. The company said measuring the frequency and severity of adverse events...
Arcutis Biotherapeutics Submits Supplemental New Drug Application to US FDA for Psoriasis Treatment
Arcutis Biotherapeutics Submits Supplemental New Drug Application to US FDA for Psoriasis Treatment
Jul 23, 2024
09:48 AM EDT, 07/23/2024 (MT Newswires) -- Arcutis Biotherapeutics ( ARQT ) said Tuesday that it has submitted a supplemental new drug application to the US Food and Drug Administration for Zoryve foam 0.3% to treat adults and adolescents aged 12 and above with scalp and body psoriasis. The submission is backed by positive results from a late-stage trial, a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved